Skip to Main Content

Author Details

Eloise Chapman-Davis
Weill Cornell Medical College
2009
68
20
PMIDPaper TitleJournal TitlePublished Year
36376567Landmark Series on Disparities: Uterine Cancer and Strategies for Mitigation.Ann Surg Oncol2023
37651980Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis.Gynecol Oncol2023
37788366Patient and provider perspectives on telemedicine use in an outpatient gynecologic clinic serving a diverse, low-income population.J Telemed Telecare2023
37934933Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis.JCO Clin Cancer Inform2023
37214514Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis.PEC Innov2023
37415958Attitudes and beliefs regarding complementary and alternative medicine in a diverse gynecologic oncology patient population.Gynecol Oncol Rep2023
37116391Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.Gynecol Oncol2023
37197889Achieving diversity in clinical trial enrollment by reducing burden and increasing value: A patient-centered approach.Gynecol Oncol2023
37062188Web-based tool for cancer family history collection: A prospective randomized controlled trial.Gynecol Oncol2023
36074132Understanding Perceived Barriers to Colposcopy Follow-Up Among Underserved Women at an Urban Teaching Hospital: A Qualitative Study.J Low Genit Tract Dis2023
36207653Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?Fam Cancer2023
36348204Expanding Medicaid Improves Outcomes in Gynecologic Malignancies, But is it Enough?Ann Surg Oncol2023
34483300Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.Int J Gynecol Pathol2022
35452249Genetic Testing for All: Overcoming Disparities in Ovarian Cancer Genetic Testing.Am Soc Clin Oncol Educ Book2022
36305018What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.Cancer2022
35960887Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.J Clin Oncol2022
35242980Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting.Gynecol Oncol Rep2022
34922769COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic.Gynecol Oncol2022
32720237Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.J Gen Intern Med2021
33710136Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.Am J Clin Oncol2021
33899220Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID-19 pandemic among low-income women in New York City.Cancer2021
34381847Sex-Related Differences in Clinical Presentation and Risk Factors for Mortality in Patients Hospitalized With Coronavirus Disease 2019 in New York City.Open Forum Infect Dis2021
34328789Leveraging Health Information Technology to Collect Family Cancer History: A Systematic Review and Meta-Analysis.JCO Clin Cancer Inform2021
34264293A Race-Conscious Analysis of the Use of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding.JAMA Oncol2021
34023131Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.Gynecol Oncol2021
33308865Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic.Gynecol Oncol2021
33294978Racial disparities in patients with coronavirus disease 2019 infection and gynecologic malignancy.Cancer2021
31633516Disparities in the Use of Adjuvant External Beam Radiation Therapy in Node-positive Cervical Cancer Patients Following Hysterectomy.Am J Clin Oncol2020
31815575Bridging the Gap: A Priorities Assessment Tool to Support Shared Decision Making, Maximize Appointment Time, and Increase Patient Satisfaction in Women With Ovarian Cancer.JCO Oncol Pract2020
31959493Primary malignant ovarian carcinoid; management and outcomes.Gynecol Oncol2020
31922918Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.J Clin Oncol2020
33204795Treatment patterns and outcomes among women with brain metastases from gynecologic malignancies.Gynecol Oncol Rep2020
32604171Molecular Profiles of Mixed Endometrial Carcinoma.Am J Surg Pathol2020
32598911Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer.Am J Obstet Gynecol2020
32847998Fertility sparing surgery for patients with FIGO stage I clear cell ovarian carcinoma: a database analysis and systematic review of the literature.Int J Gynecol Cancer2020
32981694Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals.Gynecol Oncol2020
32582376Clinicopathologic features of endometrial cancer with mismatch repair deficiency.Ecancermedicalscience2020
32448806Is hysterectomy necessary for the treatment of preinvasive stratified mucin producing intraepithelial lesions of the cervix?Int J Gynecol Cancer2020
32446719Promoting health equity in the era of COVID-19.Gynecol Oncol2020
32276935Outcomes of minimally invasive surgery for patients with endometrial carcinoma involving the cervix.Int J Gynecol Cancer2020
32256692Multiple malignant transformations of an ovarian mature cystic teratoma.Ecancermedicalscience2020
32565896Cervical carcinoma in the setting of uterovaginal prolapse: comparing standard versus tailored management.Ecancermedicalscience2020
30700566Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors.Int J Gynecol Cancer2019
31976102Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract.Case Rep Oncol Med2019
29890352Minimally Invasive Staging of Apparent Stage I Malignant Ovarian Germ Cell Tumors: Prevalence and Outcomes.J Minim Invasive Gynecol2019
31396597Evaluation of lysophosphatidic acid in vaginal fluid as a biomarker for ovarian cancer: A pilot study.Eur J Obstet Gynecol Reprod Biol X2019
31194228Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma.JAMA Oncol2019
31160074Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma.Gynecol Oncol2019
30740951Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors.J Gynecol Oncol2019
31150123Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?Cancer2019
  • 1 - 50 of 68

Recommended Authors

University of British Columbia, and Vancouver General Hospital
Career Start Year 2016
Number of shared co-authors 0
The University of British Columbia
Career Start Year 2015
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2014
Number of shared co-authors 0
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 2012
Number of shared co-authors 0
Boston University Chobanian & Avedisian School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
University of California San Diego
Career Start Year 2008
Number of shared co-authors 0
Uniformed Services of the Health Sciences Gynecologic Cancer Center of Excellence
Career Start Year 2007
Number of shared co-authors 0
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 0
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 2005
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 0
University Hospital
Career Start Year 2002
Number of shared co-authors 1
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Career Start Year 2002
Number of shared co-authors 0
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 2001
Number of shared co-authors 0
Perlmutter Cancer Center
Career Start Year 1999
Number of shared co-authors 2
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
Career Start Year 1998
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 1
John A. Burns School of Medicine, University of Hawaii
Career Start Year 1995
Number of shared co-authors 0
Westmead Hospital
Career Start Year 1995
Number of shared co-authors 0
University Medical Center, Johannes Gutenberg University Mainz
Career Start Year 1994
Number of shared co-authors 0
Barts Health NHS Trust
Career Start Year 1993
Number of shared co-authors 0
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 0
University of Glasgow
Career Start Year 1992
Number of shared co-authors 0
College of Nursing, University of South Florida
Career Start Year 1991
Number of shared co-authors 0
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 0
Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1981
Number of shared co-authors 1

Collaborators

Weill Cornell Medical College
Co-authored papers 52
Weill Cornell Medical Center
Co-authored papers 4
Weill Cornell Medical College
Co-authored papers 4
NYU Grossman School of Medicine
Co-authored papers 2
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
Dartmouth-Hitchcock Medical Center
Co-authored papers 2
Co-authored papers 2
Weill Cornell Medical Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Meyer Cancer Center
Co-authored papers 2
Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health
Co-authored papers 2
Westchester Medical Center
Co-authored papers 2
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Weill Cornell Medical College
Co-authored papers 1
Emory University School of Medicine
Co-authored papers 1
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 1
Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine
Co-authored papers 1
Liver Cancer Institute, Shanghai Medical University
Co-authored papers 1
Institute for Computational Biomedicine
Co-authored papers 1